COMMUNIQUÉS West-GlobeNewswire

UPDATE – Free Family Fun Night in Cedar Park: Ally Medical ER Ribbon Cutting
30/09/2026
EVENT UPDATE: Due to the flood watch in effect and the potential for severe weather, this event will be postponed . Please stay safe and keep an eye out for an updated date and time. The original release follows: CEDAR [...]
Native Path Collagen 2026: Launch Effective NativePath Collagen Peptides Dark Spots Bruising & Support for Skin, Hair, Joints & Bones Supplement Facts
30/09/2026
NativePath Collagen Peptides, a hydrolyzed Type I and III collagen supplement made from grass-fed bovine sources. Learn about its ingredients, formulation, and how collagen peptides are designed to complement daily [...]
Peptides Canada, Operated by Growth Guys, Announces Research-Use Peptide Supply Services for Canadian Laboratories
30/09/2026
TORONTO, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Peptides Canada has announced the availability of research-use peptide materials through its online platform, providing Canadian laboratories and researchers with access to [...]
FDA Launches Nationwide Effort to Expand Scientific Expertise and Consumer Voices to Advisory Committees
30/09/2026
Silver Spring, Md., Sept. 30, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced a broad, nationwide recruitment effort to expand the range of qualified voices and perspectives on its [...]
Inteleos Earns UN ECOSOC Status to Advance Quality Care Worldwide
30/09/2026
Special Consultative Status expands Inteleos’ ability to build health equity through global partners and policy ROCKVILLE, Md., Sept. 30, 2026 (GLOBE NEWSWIRE) -- The United Nations Economic and Social Council (ECOSOC) [...]
Sol-Gel Technologies to Host KOL Investor Day for SGT-610 on October 14, 2026
30/09/2026
NESS ZIONA, Israel, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today announced it will [...]
SK pharmteco Announces $200-Plus Million U.S. Investment to Expand Small Molecule and Peptide Capacity
30/09/2026
RANCHO CORDOVA, Calif., Sept. 30, 2026 (GLOBE NEWSWIRE) -- SK pharmteco today announced a comprehensive five-year, more than $200 million investment plan to expand and upgrade its U.S. development and manufacturing [...]
ALK expands strategic tablet supply partnership with Catalent
30/09/2026
Inside Information Agreement provides long-term expanded access to Catalent's fast-dissolving (Zydis ® ) tablet formulation technology. Supply robustness secured with prioritised manufacturing capacity increase of ~40% [...]
CJ Biomaterials Secures BPI, TÜV AUSTRIA Certifications for New PHACT™ All-PHA Compound Designed for Home Compostable Cutlery
30/09/2026
PHACT™ CB0104A earned BPI Commercial and Home Compostable, TÜV AUSTRIA OK compost HOME & OK compost INDUSTRIAL Certifications New all-PHA compound is designed for cutlery, caps, enclosures, beauty packaging, and [...]
Allarity Provides Update on Key Recent Advances Solidifying Drug Response Predictor® to Drive Stenoparib’s Clinical Development
30/09/2026
- Recently awarded patents have solidified Allarity’s strategy to leverage DRP to ensure the commercial exclusivity of stenoparib TARPON SPRINGS, Fla., September 30, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the [...]
Hyperion DeFi, Anchorage Digital, and HyperLend Together Announce the First Institutional Credit Facility on Hyperliquid
30/09/2026
Institutional Credit Layer on HyperEVM Secured by Collateral in Qualified Custody at a Federally Chartered Bank DALLAS, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “ [...]
HealthEquity Appoints Moody’s CFO Noémie Heuland to Board of Directors
30/09/2026
DRAPER, Utah, Sept. 30, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (HSA) custodian by account volume and a leader in [...]
Highlight Therapeutics Presents Positive Phase 2b Topline Results of Intralesional BO-112 in Localized Basal Cell Carcinoma as a Late-Breaker at EADV
30/09/2026
Primary composite endpoint met: 61% of patients achieved visual and pathological response across all treated lesions. Complete clinical and pathological response in 56% of high-risk head & neck patients and 62% of [...]
OneMedNet Signs Seven Figure Multiyear Agreement to Power a Partner Sold Derivative Data Solution
30/09/2026
First party, direct-from-source Real World Data will feed the Company’s tenth channel partner’s AI models and a licensable derivative dataset that partner will sell MINNEAPOLIS, Sept. 30, 2026 (GLOBE NEWSWIRE) -- [...]
Silo Pharma’s QwikAgents Expands AI Agent Platform with NVIDIA Model Support and New Runtime Flexibility
30/09/2026
Addition of NVIDIA Nemotron models and Hermes runtime expands customer choice across both AI models and agent software SARASOTA, FLA., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Silo Pharma (Nasdaq: SILO) (“Silo” or “the [...]
Avaí Bio and Austrianova Successfully Encapsulate GMP-Quality Klotho-Producing Cells, Achieve Robust Klotho Secretion
30/09/2026
LAS VEGAS, NEVADA, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”), an emerging biotech developing transformative cell-based therapies for diabetes, age-related disorders, and [...]
AIM ImmunoTech Discusses Ampligen®’s Potential to Complement Emerging Pancreatic Cancer Therapies in New CEO Corner Video
30/09/2026
Company highlights supportive survival observations, potential for biomarker-driven patient selection and upcoming Phase 2 DURIPANC milestones Access it here OCALA, Fla., Sept. 30, 2026 (GLOBE NEWSWIRE) -- AIM [...]
Ernexa Therapeutics Reports Compelling ERNA-101 Safety Results Across Three Critical IND-Enabling Studies, Advancing Toward Planned Q4 2026 IND
30/09/2026
Repeat-dose GLP toxicology study showed no ERNA-101-related adverse findings across all dose levels tested, including no clinical pathology or histopathology findings; single-dose assessment showed no evidence of acute [...]
Novo’s investigational obesity and diabetes drug CagriSema reduces ‘food noise’ and shows benefits in organ and bone health – EASD 2026
30/09/2026
In a year-long functional magnetic resonance imaging (fMRI) study - a non-invasive method to measure brain activity during specific tasks - CagriSema changed how the brain reacted to tempting, high-calorie foods in [...]

Pages